Arthrosurface believes its technology helps "bridge the gap" that exists between conservative therapies and early surgical interventions and total joint replacement surgery. There is a significant patient population with joint disease and damage which has failed early treatment therapies such as physical therapy, pain medication, arthroscopy and other surgical procedures and continues to experience chronic pain and reduced activity levels. This underserved patient population tends to be comprised of relatively young and physically active patients who are seeking therapies that can help them to maintain their active lifestyles.
As this graphic shows, there is a large underserved patient population for the HemiCAP system. These patients may be considered too old (35 years old+) for "biologic" treatments yet considered too young for most invasive surgery such as a total joint replacement which is usually reserved for older, more sedentary patients.
A typical patient that might be indicated for the HemiCAP device may have one or more of the following attributes:
Middle to older aged,
Post-traumatic degenerative disease or necrosis
Large unstable Grade IV articular defects
Significant articulating bone exposure
Failed other conservative or surgical treatments
Likely to receive a joint replacement in the future
The HemiCAP implant is intended to offer a surgical alternative to these patients who might otherwise endure years of pain and loss of function while waiting a more appropriate age for joint replacement surgery.
The surgical procedure for the HemiCAP implant allows for an outpatient procedure that is anticipated to have a relatively small degree of morbidity and a well-tolerated post-operative protocol.